Evaluation of 18F-labeled targeted perfluorocarbon-filled albumin microbubbles as a probe for microUS and microPET in tumor-bearing mice

被引:25
|
作者
Liao, Ai-Ho [2 ,3 ]
Wu, Shih-Yen [4 ]
Wang, Hsin-Ell [4 ]
Weng, Chien-Hsiu [2 ]
Wu, Ming-Fang [5 ]
Li, Pai-Chi [1 ,2 ]
机构
[1] Natl Taiwan Univ, Dept Elect Engn, Taipei 10612, Taiwan
[2] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10612, Taiwan
[3] Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei, Taiwan
[4] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan
[5] Natl Taiwan Univ, Coll Med, Anim Med Ctr, Taipei 10612, Taiwan
关键词
Targeted microbubbles; F-18-SFB; Breast cancer; MicroPET; MicroUS; ULTRASOUND CONTRAST AGENT; ANGIOGENESIS; GROWTH; BIODISTRIBUTION; PET; ENDOTHELIUM; RECEPTORS; VEGFR2;
D O I
10.1016/j.ultras.2012.06.014
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective: In this study, albumin-shelled, targeted MBs (tMBs) were first demonstrated with the expectation of visualization of biodistribution of albumin-shelled tMBs. The actual biodistribution of albumin-shelled tMBs is of vital importance either for molecular imaging or for drug delivery. Motivation: Recently, albumin microbubbles (MBs) have been studied for drug and gene delivery in vitro and in vivo through cavitation. Targeted lipid-shelled MBs have been applied for ultrasound molecular imaging and conjugated with radiolabeled antibodies for whole-body biodistribution evaluations. The novelty of the work is that, in addition to the lipid tMBs, the albumin tMBs was also applied in biodistribution detection. Methods: Multimodality albumin-shelled, F-18-SFB-labeled VEGFR2 tMBs were synthesized, and their characteristics in mice bearing MDA-MB-231 human breast cancer were investigated with micropositron-emission tomography (microPET) and high-frequency ultrasound (microUS). Results: Albumin-shelled MBs can be labeled with F-18-SFB directly and conjugated with antibodies for dual molecular imaging. The albumin-shelled tMBs show a lifetime in 30 min in the blood pool and a highly specific adherence to tumor vessels in mice bearing human breast cancer. Conclusions: From the evaluations of whole-body biodistribution, the potential of the dual molecular imaging probe for drug or gene delivery in animal experiments with albumin shelled MBs has been investigated. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:320 / 327
页数:8
相关论文
共 27 条
  • [1] A novel 18F-labeled agonist for PET imaging of stimulator of interferon gene expression in tumor-bearing mice
    Jianyang Fang
    Lixia Feng
    Lingxin Meng
    Xiaobo Wang
    Huanhuan Liu
    Lumei Huang
    Deliang Zhang
    Jingchao Li
    Rongqiang Zhuang
    Zhide Guo
    Xianzhong Zhang
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 50 : 27 - 37
  • [2] A novel 18F-labeled agonist for PET imaging of stimulator of interferon gene expression in tumor-bearing mice
    Fang, Jianyang
    Feng, Lixia
    Meng, Lingxin
    Wang, Xiaobo
    Liu, Huanhuan
    Huang, Lumei
    Zhang, Deliang
    Li, Jingchao
    Zhuang, Rongqiang
    Guo, Zhide
    Zhang, Xianzhong
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 50 (01) : 27 - 37
  • [3] MicroPET/CT of mice bearing αvβ3-expressing tumors by a 18F-labeled bifunctional chimeric RGD peptide
    Zannetti, A.
    Iommelli, F.
    Panico, M.
    Del Gatto, A.
    Zaccaro, L.
    Saviano, M.
    Pedone, C.
    Salvatore, M.
    Del Vecchio, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S476 - S476
  • [4] NOVEL 18F-LABELED VALINE DERIVATIVES: SYNTHESIS AND BIODISTRIBUTION IN MICE BEARING S180 TUMOR
    Liu, H.
    Xu, J.
    He, Y.
    Li, G.
    Ding, R.
    Zhang, S.
    Wang, X.
    Feng, M.
    Qi, C.
    Peng, C.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S202 - S202
  • [5] Synthesis and Preliminary Evaluation in Tumor Bearing Mice of New 18F-Labeled Arylsulfone Matrix Metalloproteinase Inhibitors as Tracers for Positron Emission Tomography
    Casalini, Francesca
    Fugazza, Lorenza
    Esposito, Giovanna
    Cabella, Claudia
    Brioschi, Chiara
    Cordaro, Alessia
    D'Angeli, Luca
    Bartoli, Antonietta
    Filannino, Azzurra M.
    Gringeri, Concetta V.
    Longo, Dario L.
    Muzio, Valeria
    Nuti, Elisa
    Orlandini, Elisabetta
    Figlia, Gianluca
    Quattrini, Angelo
    Tei, Lorenzo
    Digilio, Giuseppe
    Rossello, Armando
    Maiocchi, Alessandro
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (06) : 2676 - 2689
  • [6] Synthesis and Biological Evaluation of 18F-labeled FMTPD as a Focal Adhesion Kinase-Targeted Tumor Imaging Agent
    Fang, Yu
    Wang, Dawei
    Xu, Xingyu
    Zhao, Lingzhou
    Zhang, Jinming
    Zhao, Mingxia
    Lu, Xia
    Qi, Chuanmin
    Zhang, Huabei
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 : S240 - S240
  • [7] MicroPET imaging of tumor angiogenesis and monitoring on antiangiogenic therapy with an 18F labeled RGD-based probe in SKOV-3 xenograft-bearing mice
    Yang, Guangjie
    Nie, Pei
    Kong, Yu
    Sun, Hukui
    Hou, Guihua
    Han, Jiankui
    TUMOR BIOLOGY, 2015, 36 (05) : 3285 - 3291
  • [8] Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model
    Wang, HE
    Wu, SY
    Chang, CW
    Liu, RS
    Hwang, LC
    Lee, TW
    Chen, JC
    Hwang, JJ
    NUCLEAR MEDICINE AND BIOLOGY, 2005, 32 (04) : 367 - 375
  • [9] MicroPET imaging of tumor hypoxia:: Direct comparison in tumor-bearing mice of 18F-FDG, 18F-fluoro-misonidazole (FMISO) and 124I-iodo-azomycin-galactoside (IAZG).
    Zanzonico, P
    Finn, R
    Schneider, R
    Chapman, JD
    Cai, S
    Chen, Y
    Ruan, S
    Urano, M
    Beattie, B
    Pentlow, KS
    Humm, J
    Larson, SM
    Ling, C
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 278P - 278P
  • [10] STUDIES ON F-18-LABELED PYRIMIDINES .3. BIOCHEMICAL INVESTIGATION OF F-18-LABELED PYRIMIDINES AND COMPARISON WITH H-3 DEOXYTHYMIDINE IN TUMOR-BEARING RATS AND MICE
    ISHIWATA, K
    IDO, T
    ABE, Y
    MATSUZAWA, T
    MURAKAMI, M
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1985, 10 (1-2): : 39 - 44